TY - JOUR
T1 - Mutations in RAD21 disrupt regulation of apob in patients with chronic intestinal pseudo-obstruction
AU - Bonora, Elena
AU - Bianco, Francesca
AU - Cordeddu, Lina
AU - Bamshad, Michael
AU - Francescatto, Ludmila
AU - Dowless, Dustin
AU - Stanghellini, Vincenzo
AU - Cogliandro, Rosanna F.
AU - Lindberg, Greger
AU - Mungan, Zeynel
AU - Cefle, Kivanc
AU - Ozcelik, Tayfun
AU - Palanduz, Sukru
AU - Ozturk, Sukru
AU - Gedikbasi, Asuman
AU - Gori, Alessandra
AU - Pippucci, Tommaso
AU - Graziano, Claudio
AU - Volta, Umberto
AU - Caio, Giacomo
AU - Barbara, Giovanni
AU - D'Amato, Mauro
AU - Seri, Marco
AU - Katsanis, Elias Nicholas
AU - Romeo, Giovanni
AU - De Giorgio, Roberto
N1 - Funding Information:
Funding Supported by FP7-EU grant 223692 “CHERISH” (G.R.); National Institutes of Health grants 1U54HG006493 (M.B.) and P50DK096415 (N.K.); and Ricerca Finalizzata RER2009 (Ita-MNGIE), Ministry of Health , and the Italian Ministry of University and Research (PRIN/COFIN 2009MFSXNZ_002) (R.D.G.). Also supported by grants from ‘Fondazione del Monte di Bologna e Ravenna,' Bologna, Italy (R.D.G.).
Publisher Copyright:
© 2015 by the AGA Institute.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Background Aims Chronic intestinal pseudo-obstruction (CIPO) is characterized by severe intestinal dysmotility that mimics a mechanical subocclusion with no evidence of gut obstruction. We searched for genetic variants associated with CIPO to increase our understanding of its pathogenesis and to identify potential biomarkers. Methods We performed whole-exome sequencing of genomic DNA from patients with familial CIPO syndrome. Blood and lymphoblastoid cells were collected from patients and controls (individuals without CIPO); levels of messenger RNA (mRNA) and proteins were analyzed by quantitative reverse-transcription polymerase chain reaction, immunoblot, and mobility shift assays. Complementary DNAs were transfected into HEK293 cells. Expression of rad21 was suppressed in zebrafish embryos using a splice-blocking morpholino (rad21a). Gut tissues were collected and analyzed. Results We identified a homozygous mutation (p.622, encodes Ala>Thr) in RAD21 in patients from a consanguineous family with CIPO. Expression of RUNX1, a target of RAD21, was reduced in cells from patients with CIPO compared with controls. In zebrafish, suppression of rad21a reduced expression of runx1; this phenotype was corrected by injection of human RAD21 mRNA, but not with the mRNA from the mutated p.622 allele. rad21a Morpholino zebrafish had delayed intestinal transit and greatly reduced numbers of enteric neurons, similar to patients with CIPO. This defect was greater in zebrafish with suppressed expression of ret and rad21, indicating their interaction in the regulation of gut neurogenesis. The promoter region of APOB bound RAD21 but not RAD21 p.622 Ala>Thr; expression of wild-type RAD21 in HEK293 cells repressed expression of APOB, compared with control vector. The gut-specific isoform of APOB (APOB48) is overexpressed in sera from patients with CIPO who carry the RAD21 mutation. APOB48 also is overexpressed in sporadic CIPO in sera and gut biopsy specimens. Conclusions Some patients with CIPO carry mutations in RAD21 that disrupt the ability of its product to regulate genes such as RUNX1 and APOB. Reduced expression of rad21 in zebrafish, and dysregulation of these target genes, disrupts intestinal transit and the development of enteric neurons.
AB - Background Aims Chronic intestinal pseudo-obstruction (CIPO) is characterized by severe intestinal dysmotility that mimics a mechanical subocclusion with no evidence of gut obstruction. We searched for genetic variants associated with CIPO to increase our understanding of its pathogenesis and to identify potential biomarkers. Methods We performed whole-exome sequencing of genomic DNA from patients with familial CIPO syndrome. Blood and lymphoblastoid cells were collected from patients and controls (individuals without CIPO); levels of messenger RNA (mRNA) and proteins were analyzed by quantitative reverse-transcription polymerase chain reaction, immunoblot, and mobility shift assays. Complementary DNAs were transfected into HEK293 cells. Expression of rad21 was suppressed in zebrafish embryos using a splice-blocking morpholino (rad21a). Gut tissues were collected and analyzed. Results We identified a homozygous mutation (p.622, encodes Ala>Thr) in RAD21 in patients from a consanguineous family with CIPO. Expression of RUNX1, a target of RAD21, was reduced in cells from patients with CIPO compared with controls. In zebrafish, suppression of rad21a reduced expression of runx1; this phenotype was corrected by injection of human RAD21 mRNA, but not with the mRNA from the mutated p.622 allele. rad21a Morpholino zebrafish had delayed intestinal transit and greatly reduced numbers of enteric neurons, similar to patients with CIPO. This defect was greater in zebrafish with suppressed expression of ret and rad21, indicating their interaction in the regulation of gut neurogenesis. The promoter region of APOB bound RAD21 but not RAD21 p.622 Ala>Thr; expression of wild-type RAD21 in HEK293 cells repressed expression of APOB, compared with control vector. The gut-specific isoform of APOB (APOB48) is overexpressed in sera from patients with CIPO who carry the RAD21 mutation. APOB48 also is overexpressed in sporadic CIPO in sera and gut biopsy specimens. Conclusions Some patients with CIPO carry mutations in RAD21 that disrupt the ability of its product to regulate genes such as RUNX1 and APOB. Reduced expression of rad21 in zebrafish, and dysregulation of these target genes, disrupts intestinal transit and the development of enteric neurons.
KW - Animal Model
KW - Genetic Analysis
KW - Intestinal Motility
KW - Sporadic and Familial Chronic Intestinal Pseudo-obstruction
UR - http://www.scopus.com/inward/record.url?scp=84925356476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925356476&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2014.12.034
DO - 10.1053/j.gastro.2014.12.034
M3 - Article
C2 - 25575569
AN - SCOPUS:84925356476
VL - 148
SP - 771-782.e11
JO - Gastroenterology
JF - Gastroenterology
SN - 0016-5085
IS - 4
ER -